PACBPacific Biosciences of California, Inc.
$2.11+15% 1Y
$2.11
$1.1152 weeks$2.88
Is the price fair?
What PACB's price assumes
- Price / book
- 171
Price / book · as of 2026-Q1
Details›
- Price / bookas of 2026-Q1
- 171
- EV / EBIToperating margin −84%: the multiple describes the denominator
- not meaningful
- Market capitalisation310.8 million shares, counted Jul 31, 2026
- $656M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.